Chris Doering

Company: Expression Therapeutics LLC
Job title: Chief Scientific Officer
Seminars:
Strategies to Improve the Durability of Gene Therapies for Hemophilia A 10:00 am
• Assessing clinical data to understand the durability of gene therapies for Hemophilia A • Comparing different delivery methods and the impact on durability • Understanding the optimal strategy to achieve maximum durabilityRead more
day: Day Two AM